To include your compound in the COVID-19 Resource Center, submit it here.

OrbiMed closes third Asia fund at $551M

On Sept. 5, OrbiMed Advisors LLC (New York, N.Y.) closed OrbiMed Asia

Read the full 128 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE